Multimodal imaging in a pedigree of X-linked Retinoschisis with a novel RS1 variant
Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. Methods The Irish National Registry...
Saved in:
| Published in | BMC medical genetics Vol. 19; no. 1; pp. 195 - 10 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
12.11.2018
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2350 1471-2350 |
| DOI | 10.1186/s12881-018-0712-8 |
Cover
| Abstract | Background
To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected
n
= 9) with X-linked retinoschisis (XLRS1) due to a novel
RS1
mutation and to assess suitability for novel therapies using multimodal imaging.
Methods
The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males.
Results
All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel
RS1
(Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic.
Conclusions
This family has a novel gene mutation in
RS1
with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. |
|---|---|
| AbstractList | To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging.
The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males.
All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic.
This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males. All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic. This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. Methods The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males. Results All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic. Conclusions This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. Keywords: X-linked Retinoschisis, Retinoschisin, Inherited retinal dystrophy, Inherited maculopathy To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging.BACKGROUNDTo describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging.The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males.METHODSThe Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males.All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic.RESULTSAll affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic.This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease.CONCLUSIONSThis family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. Methods The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males. Results All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic. Conclusions This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. Abstract Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. Methods The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males. Results All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic. Conclusions This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging. Methods The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree. DNA sequencing was performed for each patient, one carrier female and one unaffected relative. Pedigree mapping revealed a further 4 affected males. Results All affected patients had a history of reduced visual acuity and dyschromatopsia; however, the severity of phenotype varied widely between the nine affected subjects. The stage of disease was classified as previously described. Phenotypic severity was not linearly correlated with age. A novel RS1 (Xp22.2) mutation was detected (NM_000330: c.413C > A) resulting in a p.Thr138Asn substitution. Protein modelling demonstrated a change in higher order protein folding that is likely pathogenic. Conclusions This family has a novel gene mutation in RS1 with clinical evidence of XLRS1. A proportion of the older generation has developed end-stage macular atrophy; however, the severity is variable. Confirmation of genotype in the affected grandsons of this pedigree in principle may enable them to avail of upcoming gene therapies, provided there is anatomical evidence (from multimodal imaging) of potentially reversible early stage disease. |
| ArticleNumber | 195 |
| Audience | Academic |
| Author | Stephenson, Kirk Carrigan, Matthew Wynne, Niamh Dockery, Adrian Jane Farrar, G. Kenna, Paul Keegan, David |
| Author_xml | – sequence: 1 givenname: Kirk orcidid: 0000-0002-7462-7725 surname: Stephenson fullname: Stephenson, Kirk email: kirkstephenson@hotmail.com organization: The Catherine McAuley Centre, Mater Private Hospital – sequence: 2 givenname: Adrian surname: Dockery fullname: Dockery, Adrian organization: Department of Genetics, Trinity College Dublin – sequence: 3 givenname: Niamh surname: Wynne fullname: Wynne, Niamh organization: The Research Foundation, The Royal Victoria Eye and Ear Hospital – sequence: 4 givenname: Matthew surname: Carrigan fullname: Carrigan, Matthew organization: Department of Genetics, Trinity College Dublin – sequence: 5 givenname: Paul surname: Kenna fullname: Kenna, Paul organization: The Research Foundation, The Royal Victoria Eye and Ear Hospital – sequence: 6 givenname: G. surname: Jane Farrar fullname: Jane Farrar, G. organization: Department of Genetics, Trinity College Dublin – sequence: 7 givenname: David surname: Keegan fullname: Keegan, David organization: The Catherine McAuley Centre, Mater Private Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30419843$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wA9igSGxgkeJXbGeDVFU8RipCmgGJneUkNxkPGXuwnQH-PQ5T2qYC5EUs5zvnOifnNDuyzkKWPcXoHGPJXwVMpMQFwrJAApNCPshOMBO4ILRER3f2x9lpCBuEsJCUPsqOKWK4koyeZKsP4xDN1rV6yM1W98b2ubG5znfQmt4D5K7LvxSDsV-hzZcQjXWhWZtgQv7dxHUirdvDkC9XON9rb7SNj7OHnR4CPLl-nmWf3775dPm-uPr4bnF5cVU0nIpYCCTLDnW8BCklIrzuaii1YLhkbUeZ4FXFWoR4rXFX11giSZGUGrVlSbUWhJ5li4Nv6_RG7Xy6v_-pnDbq94HzvdI-mmYAVbU1RQgE5R1nkpFKtgRhBo2khEMNyev1wWs31ltoG7DR62FmOn9jzVr1bq84obRkIhm8uDbw7tsIIaqtCQ0Mg7bgxqAIpkQQQavp3s_voRs3epuimqiSMEpQeUv1On2AsZ1Lc5vJVF2UXKafzulEnf-FSquFrWlSXTqTzmeClzNBYiL8iL0eQ1CL1XLOPrsbyk0af-qTAHwAGu9C8NDdIBipqaLqUFGVDNVUUSWTRtzTNCbqaNyUqxn-qyQHZUhTbA_-Nrd_i34Bumj1Rw |
| CitedBy_id | crossref_primary_10_1136_bcr_2021_241848 crossref_primary_10_1177_24741264221083873 crossref_primary_10_3390_genes13040615 crossref_primary_10_3892_etm_2021_10842 crossref_primary_10_1177_11206721211060141 |
| Cites_doi | 10.1016/0002-9394(76)90540-7 10.1073/pnas.1519048113 10.1016/j.exer.2018.07.021 10.1002/humu.22716 10.1111/j.1399-0004.1993.tb04433.x 10.1136/bjo.79.7.653 10.1007/s00439-013-1358-4 10.1023/A:1002432919073 10.3928/15428877-20090101-16 10.1091/mbc.e17-01-0064 10.1111/jcmm.13019 10.1093/hmg/7.7.1185 10.1093/hmg/11.24.3097 10.1038/srep33248 10.1093/hmg/ddq006 10.1038/ng1097-164 10.3390/genes8110304 10.1016/j.ajhg.2016.08.016 10.1136/bjo.2007.136127 10.1038/gim.2015.30 10.1001/archopht.118.8.1098 10.1001/archopht.1968.03850040051014 10.1093/bioinformatics/btw361 10.1167/iovs.11-8600 10.1086/507318 10.1016/j.jfma.2014.01.001 10.1093/hmg/ddu733 10.1038/msb.2011.75 10.1093/bioinformatics/btp698 10.1186/1750-1172-8-122 10.1038/ng.3703 10.1007/s10633-014-9473-7 10.1371/journal.pone.0147653 10.1016/j.preteyeres.2011.12.002 10.1016/j.ajhg.2016.04.003 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2018 COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s). 2018 – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM ISR 3V. 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
| DOI | 10.1186/s12881-018-0712-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1471-2350 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_9db300e736f6484298d2014ec8326ebe PMC6233547 A568018635 30419843 10_1186_s12881_018_0712_8 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Ireland |
| GeographicLocations_xml | – name: Ireland |
| GrantInformation_xml | – fundername: Health Research Board funderid: http://dx.doi.org/10.13039/100010414 – fundername: ; |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 NPM PMFND 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c637t-7085f0f65e888026bfbe5a74154df3476994d006ba1fbb18083088a0d553aa723 |
| IEDL.DBID | M48 |
| ISSN | 1471-2350 |
| IngestDate | Wed Aug 27 01:13:55 EDT 2025 Thu Aug 21 14:13:37 EDT 2025 Thu Sep 04 18:58:17 EDT 2025 Fri Jul 25 10:49:28 EDT 2025 Tue Jun 17 21:06:16 EDT 2025 Tue Jun 10 20:32:11 EDT 2025 Fri Jun 27 04:16:26 EDT 2025 Wed Feb 19 02:35:28 EST 2025 Thu Apr 24 23:04:03 EDT 2025 Tue Jul 01 02:46:12 EDT 2025 Sat Sep 06 07:31:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Inherited maculopathy Inherited retinal dystrophy Retinoschisin X-linked Retinoschisis |
| Language | English |
| License | Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c637t-7085f0f65e888026bfbe5a74154df3476994d006ba1fbb18083088a0d553aa723 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-7462-7725 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12881-018-0712-8 |
| PMID | 30419843 |
| PQID | 2135243205 |
| PQPubID | 44831 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9db300e736f6484298d2014ec8326ebe pubmedcentral_primary_oai_pubmedcentral_nih_gov_6233547 proquest_miscellaneous_2132727392 proquest_journals_2135243205 gale_infotracmisc_A568018635 gale_infotracacademiconefile_A568018635 gale_incontextgauss_ISR_A568018635 pubmed_primary_30419843 crossref_primary_10_1186_s12881_018_0712_8 crossref_citationtrail_10_1186_s12881_018_0712_8 springer_journals_10_1186_s12881_018_0712_8 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-11-12 |
| PublicationDateYYYYMMDD | 2018-11-12 |
| PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-12 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC medical genetics |
| PublicationTitleAbbrev | BMC Med Genet |
| PublicationTitleAlternate | BMC Med Genet |
| PublicationYear | 2018 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | 712_CR6 M Bush (712_CR7) 2016; 11 712_CR8 LC Eksandh (712_CR10) 2000; 118 HB Steele-Stallard (712_CR24) 2013; 8 L Quan (712_CR34) 2016; 32 712_CR9 NZ Gregori (712_CR13) 2009; 93 KA Jagadeesh (712_CR29) 2016; 48 M Carrigan (712_CR1) 2016; 6 712_CR14 712_CR33 712_CR32 G Tolun (712_CR20) 2016; 113 NM Ioannidis (712_CR30) 2016; 99 K Plossl (712_CR19) 2017; 21 RS Molday (712_CR11) 2012; 31 AF Deutman (712_CR39) 1976; 82 ND George (712_CR3) 1995; 79 EP Ramsay (712_CR21) 2016; 25 AI den Hollander (712_CR22) 2006; 79 K Bradshaw (712_CR44) 1999; 98 K Plossl (712_CR18) 2017; 28 DL McCulloch (712_CR45) 2015; 130 CG Sauer (712_CR17) 1997; 17 712_CR26 T Wang (712_CR40) 2002; 11 712_CR27 H Li (712_CR25) 2010; 26 M Bauwens (712_CR23) 2015; 36 C Dong (712_CR28) 2015; 24 PD Stenson (712_CR5) 2014; 133 GP Jarvik (712_CR36) 2016; 98 YH Lai (712_CR12) 2015; 114 AA Bergen (712_CR16) 1993; 43 K Plossl (712_CR37) 2018; 177 M Yanoff (712_CR38) 1968; 79 S Richards (712_CR31) 2015; 17 YV Sergeev (712_CR41) 2010; 19 MG Nittala (712_CR15) 2009; 40 F Sievers (712_CR35) 2011; 7 K Akeo (712_CR42) 2015; 2015 Adrian Dockery (712_CR2) 2017; 8 JL Duncan (712_CR43) 2011; 52 712_CR4 |
| References_xml | – volume: 82 start-page: 540 issue: 4 year: 1976 ident: 712_CR39 publication-title: Am J Ophthalmol doi: 10.1016/0002-9394(76)90540-7 – ident: 712_CR26 – volume: 113 start-page: 5287 issue: 19 year: 2016 ident: 712_CR20 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1519048113 – volume: 177 start-page: 23 year: 2018 ident: 712_CR37 publication-title: Exp Eye Res doi: 10.1016/j.exer.2018.07.021 – volume: 36 start-page: 39 issue: 1 year: 2015 ident: 712_CR23 publication-title: Hum Mutat doi: 10.1002/humu.22716 – ident: 712_CR32 – volume: 43 start-page: 113 issue: 3 year: 1993 ident: 712_CR16 publication-title: Clin Genet doi: 10.1111/j.1399-0004.1993.tb04433.x – volume: 79 start-page: 653 issue: 7 year: 1995 ident: 712_CR3 publication-title: Br J Ophthalmol doi: 10.1136/bjo.79.7.653 – volume: 133 start-page: 1 issue: 1 year: 2014 ident: 712_CR5 publication-title: Hum Genet doi: 10.1007/s00439-013-1358-4 – volume: 98 start-page: 153 issue: 2 year: 1999 ident: 712_CR44 publication-title: Doc Ophthalmol doi: 10.1023/A:1002432919073 – ident: 712_CR8 – volume: 40 start-page: 71 issue: 1 year: 2009 ident: 712_CR15 publication-title: Ophthalmic Surg Lasers Imaging doi: 10.3928/15428877-20090101-16 – volume: 28 start-page: 2178 issue: 16 year: 2017 ident: 712_CR18 publication-title: Mol Biol Cell doi: 10.1091/mbc.e17-01-0064 – volume: 21 start-page: 768 issue: 4 year: 2017 ident: 712_CR19 publication-title: J Cell Mol Med doi: 10.1111/jcmm.13019 – ident: 712_CR4 doi: 10.1093/hmg/7.7.1185 – ident: 712_CR14 – volume: 11 start-page: 3097 issue: 24 year: 2002 ident: 712_CR40 publication-title: Hum Mol Genet doi: 10.1093/hmg/11.24.3097 – volume: 6 start-page: 33248 year: 2016 ident: 712_CR1 publication-title: Sci Rep doi: 10.1038/srep33248 – ident: 712_CR6 – volume: 19 start-page: 1302 issue: 7 year: 2010 ident: 712_CR41 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddq006 – volume: 17 start-page: 164 issue: 2 year: 1997 ident: 712_CR17 publication-title: Nat Genet doi: 10.1038/ng1097-164 – volume: 8 start-page: 304 issue: 11 year: 2017 ident: 712_CR2 publication-title: Genes doi: 10.3390/genes8110304 – volume: 99 start-page: 877 issue: 4 year: 2016 ident: 712_CR30 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2016.08.016 – volume: 2015 start-page: 432782 year: 2015 ident: 712_CR42 publication-title: Case Rep Ophthalmol Med – volume: 93 start-page: 373 issue: 3 year: 2009 ident: 712_CR13 publication-title: Br J Ophthalmol doi: 10.1136/bjo.2007.136127 – volume: 17 start-page: 405 issue: 5 year: 2015 ident: 712_CR31 publication-title: Genet Med doi: 10.1038/gim.2015.30 – volume: 118 start-page: 1098 issue: 8 year: 2000 ident: 712_CR10 publication-title: Arch Ophthalmol doi: 10.1001/archopht.118.8.1098 – ident: 712_CR27 – volume: 79 start-page: 49 issue: 1 year: 1968 ident: 712_CR38 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1968.03850040051014 – volume: 32 start-page: 2936 issue: 19 year: 2016 ident: 712_CR34 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw361 – volume: 52 start-page: 9614 issue: 13 year: 2011 ident: 712_CR43 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8600 – ident: 712_CR33 – volume: 79 start-page: 556 issue: 3 year: 2006 ident: 712_CR22 publication-title: Am J Hum Genet doi: 10.1086/507318 – volume: 114 start-page: 872 issue: 9 year: 2015 ident: 712_CR12 publication-title: J Formos Med Assoc doi: 10.1016/j.jfma.2014.01.001 – ident: 712_CR9 – volume: 24 start-page: 2125 issue: 8 year: 2015 ident: 712_CR28 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu733 – volume: 7 start-page: 539 year: 2011 ident: 712_CR35 publication-title: Mol Syst Biol doi: 10.1038/msb.2011.75 – volume: 26 start-page: 589 issue: 5 year: 2010 ident: 712_CR25 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp698 – volume: 8 start-page: 122 year: 2013 ident: 712_CR24 publication-title: Orphanet J Rare Dis doi: 10.1186/1750-1172-8-122 – volume: 48 start-page: 1581 issue: 12 year: 2016 ident: 712_CR29 publication-title: Nat Genet doi: 10.1038/ng.3703 – volume: 130 start-page: 1 issue: 1 year: 2015 ident: 712_CR45 publication-title: Doc Ophthalmol doi: 10.1007/s10633-014-9473-7 – volume: 11 start-page: e0147653 issue: 1 year: 2016 ident: 712_CR7 publication-title: PLoS One doi: 10.1371/journal.pone.0147653 – volume: 31 start-page: 195 issue: 3 year: 2012 ident: 712_CR11 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2011.12.002 – volume: 25 start-page: 5311 issue: 24 year: 2016 ident: 712_CR21 publication-title: Hum Mol Genet – volume: 98 start-page: 1077 issue: 6 year: 2016 ident: 712_CR36 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2016.04.003 |
| SSID | ssj0017833 |
| Score | 2.213194 |
| Snippet | Background
To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected
n
= 9) with X-linked retinoschisis... To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to... To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to... Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis... Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis... Abstract Background To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 195 |
| SubjectTerms | Acuity Atrophy Bioinformatics Biomedical and Life Sciences Biomedicine Cell adhesion & migration Clinical-Molecular Genetics and Cytogenetics Cytogenetics Diagnosis DNA sequencing Electrophysiology Family medical history Gene Function Gene mapping Gene mutation Genetic analysis Genetic aspects Genotype & phenotype Genotypes Health aspects Human Genetics Identification and classification Inherited maculopathy Inherited retinal dystrophy Kinases Localization Males Medical imaging Methods Mutation Pathology Patients Pedigree Phenotypes Point mutation Protein folding Proteins Research Article Retina Retinal degeneration Retinography Retinoschisin Retinoschisis Tomography Visual field X-linked Retinoschisis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-koPgiWr9iq6wiCEpost95rGKpQn24s3BvyybZ1YM2Keau0P_emc3e2VTUF1-zv8BmZnY-MrMzhLxugitqHmQufGC5CDLkrmU89z44UWptQvwPefJFHZ-Kzwu5uDbqC2vCxvbAI-EOqrbmReE1V0EJA9rTtGCzhG9AFBXsALVvURWbYCrlD7ThPOUwS6MOBtDCBsNmgxd2QAVMrFBs1v-7Sr5mk27WS95ImkZbdHSf3EtOJD0cN_-A3PLdLrk9jpW82iV3TlLC_CGZxwu2530L8OV5nEhElx119AIgEGp72ge6yDGN61s6w_vPPcS7y2E5UPxFC8iuv_RndDYv6SXE1cCIR-T06OPXD8d5mqOQN4rrVa7BrQpFUNJDuAsxVx1qLx26EqINXGhVVaKF01e7MtR1acArA93jilZK7pxm_DHZ6frOPyW0YapyhjdCtgZ4wGvdtEI2vAyuZFrXGSk2dLVNajKOsy7ObAw2jLIjKyywwiIrrMnI2-0rF2OHjb-B3yOztkBsjh0fgMjYJDL2XyKTkVfIaovtLzqsr_nm1sNgP81n9lAqMNkGvLCMvEmg0MMXNC5dVwA6YMesCXJ_goTz2UyXNxJlk34YLCvB8RWcFbD8cruMb2LNW-f7dcQw9C4rlpEnowBuv5sXoqyM4BnRE9GcEGa60i2_x-7h4O9yKXRG3m2E-Ne2_kj3Z_-D7nvkLsMjiEWUbJ_srH6s_XNw6Vb1i3h6fwLaeUMC priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aUXwRrV-rVaIIgrJ0N9_7JFUsVagPVwv3FrL5aA_a3bN7V_C_d5LLXd2Kfd1MYJP5yG8ykxmE3tlgqpYGXjIfSMkCD6VxhJbeB8NqKVVI95CHP8TBMfs-5dN84TbktMq1TUyG2vU23pHvkhqgAqOk4p_mv8rYNSpGV3MLjdvoTipdBvIspxuHq5aK0hzJrJXYHcAWq-g8q_hsBwzB6CxKJfv_Ncx_nUzXsyavhU7TibT_ED3IUBLvrXj_CN3y3Ta6u2ou-Xsb3TvMYfPH6Cg9sz3vHZDPzlNfIjzrsMFzIAGH2-M-4GkZg7ne4Ul8Bd2D1zsbZgOOF7VA2fWX_gxPjmp8Cd41sOMJOt7_-vPLQZm7KZRWULkoJYCrUAXBPTi94Hm1ofXcREDBXKBMiqZhDnSwNXVo21oBNgMLZCrHOTVGEvoUbXV9558jbIlojKKWcaeYt7SV1jFuaR1MTaRsC1St91XbXGo8drw408nlUEKvWKGBFTqyQqsCfdhMma_qbNxE_Dkya0MYS2SnD_3Fic4apxvX0qrykoogmIJjVzkAO_C7YMMEiG6B3kZW61gEo4tZNidmOQz629FE73EBB7cCLFag95ko9LACa_KjBdiHWDdrRLkzogQttePhtUTpbCUGfSXTBXqzGY4zY-Zb5_tloiERYzakQM9WArhZN61Y3ShGCyRHojnamPFINztNNcQB9VLOZIE-roX46rf-u-8vbl7ES3SfROWKSZJkB20tLpb-FUC2Rfs66eUffzY7AA priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9UwFA86UXwRnV_VKVEEQSm2-e7jHI4pzId7Hdy3kDaJFrZ22HsH_veepLl1nR_ga_MLtOf79OScIPSq8aaoqec5c57kzHOfG0to7pw3rJRS-fgf8vizODphn1Z8lYZFh16Yy_X7Uol3A9hPFRJeFVptQHmvoxu8pCLWZcXBVDCQitJUtPzjtpnbidP5f7fBl5zQ1QOSV6qk0fkc3kV3UtSI90c230PXXLeLbo73SP7YRbeOU4X8PlrGjtqz3gK8PYtXEOG2wwafAwRya4d7j1d5qNs6ixeh4bmHBLcd2gGHf7KA7PoLd4oXyxJfQCINlH-ATg4_fDk4ytPFCXkjqFznEuIoX3jBHeS3kGTVvnbchNiBWU-ZFFXFLKhbbUpf16WCMAyMjSks59QYSehDtNP1nXuMcENEZRRtGLeKuYbWsrGMN7T0piRS1hkqtnTVTZoqHi63ONUxu1BCj6zQwAodWKFVht5MW87HkRr_Ar8PzJqAYRp2fABCopNy6crWtCicpMILpsDDKgtxDbwumCsBUpqhl4HVOsy76MKBmq9mMwz643Kh97kAH60g7MrQ6wTyPXxBY1J_AtAhjMiaIfdmSFDIZr68lSidDMKgSQmRLqOkgOUX03LYGQ65da7fRAwJ4WRFMvRoFMDpu2nBykoxmiE5E80ZYeYrXfstjguHAJdyJjP0divEv17rr3R_8l_op-g2CboWjkeSPbSz_r5xzyBYW9fPo5r-BOvIM5o priority: 102 providerName: Springer Nature |
| Title | Multimodal imaging in a pedigree of X-linked Retinoschisis with a novel RS1 variant |
| URI | https://link.springer.com/article/10.1186/s12881-018-0712-8 https://www.ncbi.nlm.nih.gov/pubmed/30419843 https://www.proquest.com/docview/2135243205 https://www.proquest.com/docview/2132727392 https://pubmed.ncbi.nlm.nih.gov/PMC6233547 https://doaj.org/article/9db300e736f6484298d2014ec8326ebe |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_tQ0x7QTC-AqMKCAkJlJHEju0-ILRVmwZSJ9RSqW-Wk9gjUpeMpp3Yf8_ZTToyBg88Nj6ryX347uez7wDeZEaFKTFJQLWJA2oSE6g8JoHWRtGIc2HcPuTwjJ1O6JdpMt2Atr1Vw8D6Tmhn-0lN5rODnz-uP6HBf3QGL9iHGtdYYUGxsNdx0MA3YRsdE7NYbEhvkgpcENIkNu-ctgs7CO4RhVPS8VKumP-fS_ZvPuv2ecpbSVXnq04ewP0myPQPV1rxEDZ0uQf3Vm0nr_dgZ9gk1B_B2F3AvahyJC8uXMcivyh95V8iCUJx7VfGnwY2zatzf2TvR1fItKIuat9u4SJlWV3pmT8aR_4V4m4U1GOYnBx_G5wGTZ-FIGOELwKOYZcJDUs0wmHEZKlJdaJsqEFzQyhn_T7N0TpTFZk0jQRGbbg2qTBPEqIUj8kT2CqrUj8DP4tZXwmS0SQXVGck5VlOk4xERkUx56kHYctXmTVFyG0vjJl0YEQwuZKKRKlIKxUpPHi3nnK5qsDxL-IjK6w1oS2e7R5U83PZ2KLs5ykJQ80JM4wKdMgixzAIXxdXN4ZK7cFrK2ppy2OU9vzNuVrWtfw8HsnDhKFLFxilefC2ITIVfkGmmusMyAdbUatDud-hRPvNusOtRslW_WUcYWBMSRzi8Kv1sJ1pz8SVulo6mthGn_3Yg6crBVx_d6vHHvCOanYY0x0pi--uujjGwySh3IP3rRLfvNZf-f78v__nBezG1gTtycp4H7YW86V-iXHeIu3BJp_yHmwfHZ99HeGvARv03J5Jz9l1z23N_QJSklDS |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1Jo2cXlBMG6BAQGBkJiiJbEdOw8IbbCpZWuF2k3qm3ESe1TakrK0Q_spvpFzcunIEHvba3wsxT53nxshb1Or_YRa7jFjQ49Zbj2dhdQzxmoWCCFt9Q45GEa9I_Z1wicr5HdbC4Npla1MrAR1VqT4Rr4VBmAqMBr6_NPsp4dTozC62o7QqMli31z8Apet_Nj_Avh9F4Z7u4efe14zVcBLIyrmngAjw_o24gacP_BAEpsYrlGxssxSJqI4ZhnQYqIDmySBBBsFOFH7GedUa4GNDkDkrzGsaF0lazu7w2-jZdxCSEqb2Gkgo60SpL9Ed11ioRCIno72q4YE_KsK_tKFV_M0rwRrKx24d5_ca4xXd7umtgdkxeTr5FY9zvJindweNIH6h2RcFfaeFhmAT0-rSUjuNHe1OwMQcPGNW1h34mH42GTuCOuuC_Czp-W0dPFpGCDz4tycuKNx4J6DPw8E8Igc3chNPyareZGbp8RNwyjWkqaMZ5KZlCYizRhPaWB1EAqROMRv71WlTXNznLFxoionR0aqRoUCVChEhZIO-bDcMqs7e1wHvIPIWgJiU-7qQ3F2rBoeV3GWUN83gkY2YhIUvczAvILfBakZAbM45A2iWmHbjRzzeo71oixVfzxS2zwCU0GC9eeQ9w2QLeAEqW7KJOAesFNXB3KjAwlyIe0utxSlGrlUqksucsjr5TLuxFy73BSLCiZEqzYOHfKkJsDluanPglgy6hDRIc3OxXRX8umPqms52NmUM-GQzZaIL3_rv_f-7PpDvCJ3eoeDA3XQH-4_J3dDZDRM0Qw3yOr8bGFegME4T142XOqS7zctGP4AKWx3oQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1ra9RAcNGKxS9F6yu1ahRBUEKTfedjrR6t2iJ3Fu7bssnu1oM2OZq7gv_emSR3mvoAv2ZnIZn3ZF6EvCqDTQsWRMJ9oAkPIiTWUZZ4HyzPlNKh_Q95fCIPT_nHqZj2e06bVbX7KiXZ9TTglKZqsTd3oRNxLfca0Koaw2CNDTgg0jfJLY6WD7O18mCdRlCasT6V-cdrA2PUzuz_XTP_Ypqul01ey522Jml0l2z1vmS83xH_Hrnhq21yu9su-X2bbB73efP7ZNL22V7UDsBnF-1ionhWxTaeAwhE3D6uQzxNEC3exWNsg64h7J01sybGP7UAWdVX_jweT7L4CsJroMcDcjr68PXgMOnXKSSlZGqRKPCuQhqk8BD1QuhVhMILix4Fd4FxJfOcOxDCwmahKDINzhmoIJs6IZi1irKHZKOqK_-YxCWVudWs5MJp7ktWqNJxUbIs2IwqVUQkXeHVlP2scVx5cW7amENL05HCACkMksLoiLxZX5l3gzb-BfwOibUGxBnZ7YP68sz0ImdyV7A09YrJILkGu6sdeDvwuqDEJPBuRF4iqQ1OwaiwzObMLpvGHE3GZl9IsNwanLGIvO6BQg1fUNq-awHwgIOzBpC7A0gQ03J4vOIo06uJxtAM_F_OaArHL9bHeBNL3ypfL1sYik5mTiPyqGPA9XezlGe55iwiasCaA8QMT6rZt3aIOLi9THAVkbcrJv75Wn_F-85_QT8nm1_ej8zno5NPT8gdimKH9ZN0l2wsLpf-KXhzi-JZK7E_AJXOPs4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multimodal+imaging+in+a+pedigree+of+X-linked+Retinoschisis+with+a+novel+RS1+variant&rft.jtitle=BMC+medical+genetics&rft.au=Stephenson%2C+Kirk&rft.au=Dockery%2C+Adrian&rft.au=Wynne%2C+Niamh&rft.au=Carrigan%2C+Matthew&rft.date=2018-11-12&rft.pub=BioMed+Central&rft.eissn=1471-2350&rft.volume=19&rft_id=info:doi/10.1186%2Fs12881-018-0712-8&rft_id=info%3Apmid%2F30419843&rft.externalDocID=PMC6233547 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2350&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2350&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2350&client=summon |